Home Compare BMY vs FFIV
Stock Comparison · Single-driver result

Bristol-Myers Squibb Company vs F5: Which Stock Looks Stronger in 2026?

The structural profiles are close, with F5 carrying a narrow edge on profitability. Bristol-Myers Squibb Company still leads on growth and valuation, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead runs through profitability, while growth still acts as a real counterweight on the other side.

Trajectory Similarity
0.67
Moderately similar
Peer-set rank: #11
within Bristol-Myers Squibb Company's functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The strongest overlap appears in revenue stability and investment intensity.

Similarity drivers
revenue stabilityinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BMY
Bristol-Myers Squibb Company
61
Peer-Score
Signal qualityHigh
vs
FFIV
F5, Inc.
65
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in profitability.

Dimension spread: BMY vs FFIV Profitability 38 77 Stability 56 70 Valuation 86 76 Growth 62 26 BMY FFIV
Gap Ranking
#1 Profitability +39
#2 Growth +36
#3 Stability +14
#4 Valuation +10
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BMY and FFIV Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BMYFFIV Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against F5, Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
On profitability, F5, Inc. ranks near the top of the group; Bristol-Myers Squibb Company sits in the weaker half.
Growth
Bristol-Myers Squibb Company sits in the stronger part of the group on growth, while F5, Inc. is closer to mid-pack.
Profitability — Dominant Gap
BMY
38
FFIV
77
Gap+39in favour of FFIV

Capital efficiency adds support, with a 10.8-point ROIC advantage.

What keeps the gap from being one-sided

Earnings growth also leans the other way, which keeps the score lead from reading as a full growth sweep.

What this means for the comparison

Profitability is the clearest driver of the lead, with growth adding further support — though growth still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the BMY vs FFIV comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BMY and FFIV each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.